Or Pfizer can just increase the price to the high end valuation, what's $90M USD to Pfizer given the massive revenue potential for acute respiratory diagnosis (children and adult) and chronic respiratory management for Asthma (children and adult) and COPD (adult)......
- Forums
- ASX - By Stock
- RAP
- No-vote letter update
No-vote letter update, page-208
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online